Comparison_NN of_IN C18-Carboxypropylbetaine_NP and_CC Standard_NP N-Acetyl-l-Cysteine-NaOH_NP Processing_NP of_IN Respiratory_NP Specimens_NP for_IN Increasing_VBG Tuberculosis_NN Smear_NP Sensitivity_NP in_IN Brazil_NP Techniques_NP to_TO improve_VB the_DT sensitivity_NN of_IN smear_NN microscopy_NN would_MD facilitate_VB early_JJ tuberculosis_NN (_( TB_NN )_) diagnosis_NN and_CC disease_NN control_NN ,_, especially_RB in_IN low-income_JJ countries_NNS where_WRB the_DT positive_JJ predictive_JJ value_NN is_VBZ high_JJ ._SENT C18-carboxypropylbetaine_NP (_( CB-18_NP )_) is_VBZ a_DT zwitterionic_JJ detergent_NN that_WDT helps_VBZ to_TO compensate_VB for_IN the_DT innate_JJ buoyancy_NN of_IN mycobacteria_NNS ,_, potentially_RB enhancing_VBG recovery_NN by_IN centrifugation_NN ._SENT Previous_JJ data_NNS suggest_VBP that_IN CB-18_NP may_MD increase_VB the_DT sensitivity_NN of_IN smear_NN ,_, culture_NN ,_, and_CC molecular_JJ amplification_NN diagnostic_JJ testing_NN ._SENT The_DT goal_NN of_IN the_DT present_JJ study_NN was_VBD to_TO evaluate_VB if_IN the_DT sensitivity_NN of_IN the_DT smear_NN technique_NN using_VBG light_JJ microscopy_NN could_MD be_VB improved_VBN by_IN treating_VBG respiratory_JJ samples_NNS with_IN CB-18_NP ._SENT In_IN the_DT first_JJ phase_NN ,_, respiratory_JJ specimens_NNS were_VBD collected_VBN consecutively_RB from_IN patients_NNS with_IN suspected_JJ pulmonary_JJ tuberculosis_NN in_IN a_DT tertiary-care_NN hospital_NN in_IN Rio_NP de_NP Janeiro_NP ,_, Brazil_NP (_( 236_CD specimens_NNS were_VBD analyzed_VBN )_) ._SENT After_IN protocol_NN modifications_NNS ,_, another_DT 120_CD respiratory_JJ specimens_NNS were_VBD evaluated_VBN ._SENT The_DT standard_JJ technique_NN was_VBD N-acetyl-l-cysteine_JJ with_IN sodium_NN hydroxide_NN (_( NALC-NaOH_NP )_) treatment_NN ,_, smear_NN concentration_NN with_IN centrifugation_NN ,_, and_CC Ziehl-Neelsen_NP staining_VBG ._SENT Culture_NN on_IN Lowenstein-Jensen_NP slants_NNS was_VBD performed_VBN on_IN all_DT specimens_NNS for_IN use_NN as_IN the_DT "_`` gold_JJ standard_NN ._SENT "_`` No_DT specimens_NNS from_IN patients_NNS undergoing_VBG active_JJ TB_NN treatment_NN were_VBD included_VBN ._SENT The_DT initial_JJ protocol_NN for_IN CB-18_NP processing_NN resulted_VBD in_IN a_DT sensitivity_NN of_IN 59.6_CD %_NN and_CC specificity_NN of_IN 96.8_CD %_NN compared_VBN to_TO standard_JJ processing_NN with_IN a_DT sensitivity_NN of_IN 66.0_CD %_NN and_CC specificity_NN of_IN 96.8_CD %_NN ._SENT Using_VBG the_DT modified_JJ protocol_NN ,_, the_DT sensitivity_NN of_IN CB-18_NP increased_VBD to_TO 71.4_CD %_NN with_IN a_DT specificity_NN of_IN 97.0_CD %_NN versus_IN standard_JJ processing_NN with_IN a_DT sensitivity_NN of_IN 61.9_CD %_NN and_CC a_DT specificity_NN of_IN 99.0_CD %_NN ._SENT The_DT diagnostic_JJ yield_NN of_IN acid-fast_JJ bacillus_NN smear_NN with_IN CB-18_NP in_IN the_DT absence_NN of_IN fluorescence_NN microscopy_NN and_CC PCR_NP compared_VBN to_TO standard_JJ processing_NN with_IN NALC-NaOH_NP was_VBD not_RB significantly_RB different_JJ ,_, although_IN the_DT power_NN to_TO detect_VB a_DT difference_NN by_IN the_DT modified_JJ assay_NN was_VBD low_JJ ._SENT Tuberculosis_NN (_( TB_NN )_) remains_VBZ one_CD of_IN the_DT deadliest_JJS diseases_NNS worldwide_RB ,_, with_IN an_DT estimated_VBN 8.4_CD million_CD new_JJ cases_NNS and_CC over_IN 2_CD million_CD deaths_NNS each_DT year_NN ._SENT Smear_NN microscopy_NN is_VBZ currently_RB the_DT most_RBS feasible_JJ microbiological_JJ method_NN for_IN diagnosis_NN of_IN pulmonary_JJ TB_NN in_IN developing_VBG countries_NNS due_JJ to_TO its_PP$ rapidity_NN ,_, low_JJ cost_NN ,_, and_CC high_JJ positive_JJ predictive_JJ value_NN for_IN Mycobacterium_NN tuberculosis_NN ._SENT However_RB ,_, sputum_NN smear_NN microscopy_NN with_IN Ziehl-Neelsen_NP staining_VBG is_VBZ only_RB 60_CD to_TO 70_CD %_NN sensitive_JJ for_IN the_DT diagnosis_NN of_IN pulmonary_JJ TB_NN compared_VBN with_IN sputum_NN culture_NN ._SENT Among_IN human_JJ immunodeficiency_NN virus-infected_JJ persons_NNS the_DT sensitivity_NN of_IN sputum_NN Ziehl-Neelsen_NP smears_VBZ has_VBZ been_VBN reported_VBN to_TO be_VB even_RB lower_JJR ._SENT Delayed_VBN or_CC missed_VBN diagnoses_NNS contribute_VBP to_TO M._NP tuberculosis_NN transmission_NN and_CC mortality_NN due_JJ to_TO TB_NN ._SENT Improvements_NNS in_IN the_DT sensitivity_NN of_IN smear_NN microscopy_NN would_MD allow_VB earlier_JJR diagnosis_NN ._SENT TB_NN programs_NNS could_MD then_RB optimize_VB disease_NN control_NN from_IN a_DT public_JJ health_NN standpoint_NN as_IN well_RB as_RB improve_VB individual_JJ patient_JJ management_NN ._SENT In_IN previously_RB published_VBN reports_NNS ,_, homogenization_NN and_CC concentration_NN of_IN respiratory_JJ specimens_NNS by_IN centrifugation_NN have_VBP been_VBN shown_VBN to_TO improve_VB acid-fast_JJ bacillus_NN (_( AFB_NP )_) smear_NN sensitivity_NN ._SENT Recently_RB ,_, another_DT method_NN for_IN processing_VBG respiratory_JJ specimens_NNS using_VBG N,N-dimethyl-N-(n-octadecyl)-N-(3-carboxypropyl)ammonium_NP inner_JJ salt_NN ,_, also_RB known_VBN as_IN C18-carboxypropylbetaine_NP (_( CB-18_NP )_) ,_, has_VBZ been_VBN reported_VBN to_TO result_VB in_IN a_DT higher_JJR sputum_NN smear_NN sensitivity_NN ._SENT CB-18_NP is_VBZ a_DT zwitterionic_JJ detergent_NN that_WDT is_VBZ taken_VBN up_RP by_IN viable_JJ mycobacteria_NNS ,_, making_VBG them_PP more_RBR dense_JJ and_CC thereby_RB increasing_VBG their_PP$ recovery_NN by_IN centrifugation_NN ._SENT It_PP has_VBZ been_VBN shown_VBN that_IN CB-18_NP smear_NN processing_NN combined_VBN with_IN the_DT use_NN of_IN fluorescent_JJ stains_NNS significantly_RB improves_VBZ the_DT sensitivities_NNS of_IN AFB_NP smears_NNS for_IN M._NP tuberculosis_NN (_( -_: )_) ._SENT The_DT purpose_NN of_IN this_DT study_NN was_VBD to_TO compare_VB light_JJ microscopy_NN results_NNS of_IN respiratory_JJ specimens_NNS processed_VBN by_IN standard_JJ techniques_NNS and_CC by_IN CB-18_NP treatment_NN for_IN the_DT diagnosis_NN of_IN pulmonary_JJ tuberculosis_NN in_IN a_DT high-_NN prevalence_NN setting_NN ._SENT Subjects_NNS and_CC setting_VBG ._SENT |_SYM Study_NP participants_NNS were_VBD drawn_VBN from_IN the_DT Outpatient_JJ and_CC Inpatient_JJ Units_NNS of_IN the_DT Hospital_NP Universitario_NP Clementino_NP Fraga_NP Filho_NP (_( HUCFF_NP )_) ,_, Rio_NP de_NP Janeiro_NP ,_, Brazil_NP ._SENT The_DT first_JJ phase_NN of_IN the_DT study_NN included_VBD samples_NNS collected_VBN between_IN October_NP 1999_CD and_CC March_NP 2000_CD ,_, and_CC the_DT second_JJ phase_NN included_VBD samples_NNS collected_VBN between_IN July_NP and_CC September_NP 2000_CD ._SENT Consecutive_JJ respiratory_JJ samples_NNS sent_VBD to_TO the_DT laboratory_NN from_IN adult_JJ patients_NNS with_IN suspected_JJ active_JJ pulmonary_JJ TB_NN were_VBD included_VBN in_IN the_DT study_NN ._SENT The_DT reference_NN standard_NN for_IN the_DT diagnosis_NN of_IN pulmonary_JJ tuberculosis_NN was_VBD culture_NN growth_NN of_IN M._NP tuberculosis_NN ._SENT Approval_NN for_IN this_DT study_NN was_VBD granted_VBN by_IN the_DT Institutional_NP Review_NP Boards_NPS of_IN HUCFF_NP ,_, the_DT Brazilian_JJ Ministry_NP of_IN Health_NP ,_, and_CC the_DT Johns_NP Hopkins_NP Medical_NP Institutions_NP ._SENT Written_VBN informed_JJ consent_NN was_VBD obtained_VBN from_IN all_DT study_NN subjects_NNS ._SENT Specimen_NN collection_NN ._SENT |_SYM Respiratory_NP specimens_NNS submitted_VBD to_TO the_DT mycobacteriology_NN laboratory_NN with_IN culture_NN request_NN were_VBD included_VBN ._SENT A_DT total_NN of_IN 236_CD specimens_NNS were_VBD analyzed_VBN during_IN the_DT initial_JJ phase_NN ,_, and_CC an_DT additional_JJ 120_CD specimens_NNS were_VBD analyzed_VBN using_VBG the_DT modified_JJ protocol_NN ._SENT Each_DT specimen_NN with_IN a_DT volume_NN of_IN 5_CD ml_NN or_CC greater_JJR was_VBD split_VBN and_CC processed_VBN by_IN the_DT standard_JJ digestion-decontamination_NN method_NN that_WDT combines_VBZ N-acetyl-l-cysteine_NP (_( NALC_NP )_) and_CC sodium_NN hydroxide_NN (_( NALC-NaOH_NP )_) and_CC by_IN the_DT CB-18_NP method_NN ._SENT NALC-NaOH_NN processing_NN ._SENT |_SYM The_DT respiratory_JJ samples_NNS were_VBD incubated_VBN for_IN 20_CD min_NN with_IN 2.0_CD %_NN NALC-2.0_NP %_NN NaOH_NP ,_, and_CC then_RB centrifuged_VBN at_IN 3,000_CD x_NN g_NN for_IN 20_CD min_NN ._SENT The_DT samples_NNS were_VBD decanted_VBN ,_, and_CC the_DT sediment_NN was_VBD resuspended_VBN in_IN the_DT remaining_VBG supernatant_JJ ._SENT All_DT specimens_NNS were_VBD then_RB stained_VBN for_IN AFB_NP and_CC cultured_VBD as_RB described_VBN below_RB ._SENT CB-18_JJ processing_NN ._SENT |_SYM The_DT CB-18_NP smear_NN kit_NN provided_VBN by_IN the_DT manufacturer_NN (_( Integrated_NP Research_NP Technology_NP ,_, LLC_NP ,_, Baltimore_NP ,_, Md._NP )_) included_VBD 20x_JJ Tris-citrate_NN buffer_NN ,_, CB-18_NP stock_NN ,_, and_CC NALC_NP ._SENT In_IN the_DT initial_JJ manufacturer_NN 's_POS protocol_NN ,_, respiratory_JJ specimens_NNS were_VBD treated_VBN with_IN a_DT buffered_VBN solution_NN of_IN 1_CD mM_NP CB-18_NP in_IN Tris-citrate_NP buffer_NN (_( 50_CD mM_NP Tris-HCl_NP ,_, 12.5_CD mM_JJ citrate_NN [_SYM pH_NN 7.6_CD ]_SYM ,_, 1.5_CD mM_NP NaCl_NP )_) with_IN 15_CD mM_NP NALC_NP ._SENT The_DT samples_NNS were_VBD mixed_VBN with_IN buffered_VBN CB-18_NP and_CC immediately_RB subjected_VBN to_TO centrifugation_NN at_IN 3,000_CD x_NN g_NN for_IN 20_CD min_NN at_IN 25C_JJ ._SENT The_DT samples_NNS were_VBD decanted_VBN ,_, resuspended_VBN in_IN the_DT remaining_VBG supernatant_JJ ,_, and_CC then_RB used_VBN to_TO prepare_VB smears_NNS for_IN diagnostic_JJ evaluation_NN ._SENT In_IN the_DT second_JJ phase_NN of_IN the_DT study_NN ,_, the_DT manufacturer_NN introduced_VBD modifications_NNS that_IN included_VBN (_( i_NP )_) increasing_VBG the_DT concentration_NN of_IN CB-18_NP to_TO 4_CD mM_NN ,_, (_( ii_NNS )_) lowering_VBG the_DT pH_NN of_IN the_DT buffer_NN to_TO pH_NN 6.0_CD ,_, and_CC (_( iii_NNS )_) incubating_VBG specimens_NNS in_IN the_DT CB-18_NP solution_NN for_IN 90_CD min_NN ._SENT In_IN addition_NN ,_, in_IN the_DT second_JJ phase_NN of_IN the_DT study_NN ,_, samples_NNS were_VBD initially_RB homogenized_VBN in_IN an_DT equal_JJ volume_NN of_IN 15_CD mM_NP NALC-50_NP mM_NP NaOH-2.9_NP %_NN sodium_NN citrate_NN for_IN 15_CD min_NN prior_JJ to_TO addition_NN of_IN the_DT CB-18_NP solution_NN ._SENT Following_VBG the_DT incubation_NN ,_, samples_NNS were_VBD again_RB subjected_VBN to_TO centrifugation_NN at_IN 3,000_CD x_NN g_NN for_IN 20_CD min_NN ,_, decanted_VBD ,_, and_CC then_RB resuspended_JJ in_IN the_DT remaining_VBG supernatant_JJ for_IN smear_NN analysis_NN ._SENT AFB_NN smears_NNS ._SENT |_SYM Smears_NP made_VBN from_IN the_DT NALC-NaOH_NP and_CC CB-18_NP protocols_NNS were_VBD heat_NN fixed_VBN and_CC stained_VBN using_VBG the_DT Ziehl-Neelsen_NP (_( ZN_NP )_) technique_NN for_IN AFB_NP staining_VBG ._SENT A_DT small_JJ number_NN of_IN specimens_NNS (_( 85_CD specimens_NNS )_) processed_VBN with_IN CB-18_NP were_VBD also_RB stained_VBN with_IN the_DT Kinyoun_NP staining_VBG technique_NN as_RB well_RB as_IN ZN_NP ._SENT The_DT smears_NNS were_VBD scanned_VBN at_IN x1,000_JJ magnification_NN with_IN a_DT light_JJ microscope_NN ._SENT The_DT results_NNS were_VBD quantified_VBN in_IN accordance_NN with_IN published_JJ standards_NNS ._SENT For_IN quality_NN assurance_NN ,_, an_DT experienced_JJ scientist_NN in_IN the_DT Mycobacteriology_NP Laboratory_NP at_IN HUCFF_NP reread_VBD 10_CD %_NN of_IN the_DT negative_JJ smears_NNS and_CC all_PDT the_DT positive_JJ smears_NNS ._SENT Culture_NN ._SENT |_SYM A_DT portion_NN of_IN each_DT processed_JJ sediment_NN was_VBD removed_VBN for_IN smear_NN analysis_NN ._SENT The_DT specimen_NN was_VBD then_RB resuspended_VBN in_IN 2.5_CD ml_NN of_IN distilled_JJ water_NN ._SENT Lowenstein-Jensen_NP slants_NNS were_VBD inoculated_VBN with_IN approximately_RB 0.4_CD ml_NN of_IN the_DT resuspended_JJ sediment_NN and_CC incubated_VBN at_IN 37C_JJ for_IN 8_CD weeks_NNS ._SENT All_DT specimens_NNS that_WDT were_VBD culture_NN positive_JJ for_IN mycobacteria_NNS were_VBD tested_VBN by_IN standard_JJ biochemical_JJ methods_NNS to_TO distinguish_VB M._NP tuberculosis_NN from_IN nontuberculous_JJ mycobacteria_NNS ,_, as_RB described_VBN elsewhere_RB ._SENT Statistical_JJ analyses_NNS ._SENT |_SYM Analyses_NPS were_VBD carried_VBN out_IN using_VBG STATA_NP 6.0_CD statistical_JJ software_NN ._SENT Sensitivity_NN ,_, specificity_NN ,_, and_CC positive_JJ and_CC negative_JJ predictive_JJ values_NNS were_VBD calculated_VBN for_IN each_DT method_NN ._SENT Fisher_NP 's_POS test_NN and_CC McNemar_NP 's_POS test_NN were_VBD used_VBN for_IN comparisons_NNS of_IN results_NNS ._SENT Agreement_NN between_IN the_DT two_CD AFB_NP staining_VBG methods_NNS was_VBD evaluated_VBN using_VBG the_DT kappa_NN score_NN ._SENT During_IN the_DT course_NN of_IN the_DT study_NN ,_, 494_CD samples_NNS collected_VBN from_IN patients_NNS suspected_VBN of_IN having_VBG active_JJ pulmonary_JJ tuberculosis_NN were_VBD processed_VBN by_IN the_DT NALC-NaOH_NP and_CC CB-18_NP processing_NN methods_NNS ._SENT In_IN the_DT initial_JJ phase_NN of_IN the_DT project_NN ,_, 368_CD specimens_NNS were_VBD collected_VBN ;_: of_IN those_DT ,_, 132_CD were_VBD not_RB included_VBN in_IN the_DT analysis_NN ._SENT Reasons_NNS for_IN exclusion_NN were_VBD flaking_VBG and_CC washing_VBG away_RB of_IN the_DT smear_NN during_IN staining_VBG after_IN CB-18_NP processing_NN (_( n_NN =_SYM 53_CD )_) ,_, anti-TB_NN treatment_NN started_VBD more_JJR than_IN 4_CD weeks_NNS before_IN sample_NN collection_NN (_( n_NN =_SYM 18_CD )_) ,_, culture_NN contamination_NN (_( n_NN =_SYM 15_CD )_) ,_, and_CC failure_NN to_TO culture_VB (_( n_NN =_SYM 46_CD )_) ._SENT For_IN the_DT modified_JJ protocol_NN ,_, 126_CD specimens_NNS were_VBD collected_VBN ;_: of_IN those_DT ,_, 6_CD were_VBD lost_VBN and_CC were_VBD not_RB included_VBN in_IN the_DT analysis_NN :_: flaking_VBG and_CC washing_VBG away_RB of_IN the_DT smear_NN during_IN staining_VBG with_IN CB-18_NP processing_NN (_( n_NN =_SYM 1_CD )_) and_CC anti-TB_NN treatment_NN started_VBD more_JJR than_IN 4_CD weeks_NNS before_IN sample_NN collection_NN (_( n_NN =_SYM 5_CD )_) ._SENT The_DT 417_CD specimens_NNS evaluated_VBN included_VBD different_JJ types_NNS of_IN respiratory_JJ specimens_NNS ,_, including_VBG spontaneous_JJ sputum_NN (_( 54_CD %_NN )_) ,_, induced_VBN sputum_NN (_( 28_CD %_NN )_) ,_, bronchoalveolar_JJ lavage_NN (_( 13_CD %_NN )_) ,_, bronchial_JJ lavage_NN (_( 4_CD %_NN )_) ,_, and_CC bronchial_JJ aspirate_NN (_( 1_CD %_NN )_) ._SENT Samples_NNS other_JJ than_IN spontaneous_JJ sputum_NN showed_VBD no_DT significant_JJ differences_NNS among_IN techniques_NNS (_( standard_JJ ,_, original_JJ and_CC modified_JJ CB-18_JJ protocols_NNS [_SYM data_NNS not_RB shown_VBN ]_SYM )_) ._SENT Overall_RB ,_, 68_CD samples_NNS (_( 16_CD %_NN )_) had_VBD cultures_NNS that_WDT grew_VBD M._NP tuberculosis_NN ._SENT Comparison_NN of_IN processing_NN methods_NNS ._SENT |_SYM In_IN the_DT first_JJ phase_NN ,_, M._NP tuberculosis_NN culture_NN growth_NN was_VBD identified_VBN in_IN 47_CD samples_NNS ,_, and_CC in_IN the_DT second_JJ phase_NN another_DT 21_CD samples_NNS were_VBD culture_NN positive_JJ ._SENT The_DT initial_JJ CB-18_NP protocol_NN was_VBD slightly_RB less_RBR sensitive_JJ than_IN routine_JJ ZN_NP smears_NNS ,_, 59.6_CD %_NN (_( 28_CD of_IN 47_CD )_) versus_CC 66.0_CD %_NN (_( 31_CD of_IN 47_CD )_) (_( P_NN =_SYM 0.29_CD )_) ._SENT During_IN the_DT first_JJ phase_NN of_IN the_DT study_NN ,_, there_EX was_VBD no_DT significant_JJ difference_NN in_IN the_DT positive_JJ predictive_JJ value_NN between_IN NALC-NaOH_NP decontamination_NN and_CC the_DT CB-18_NP processing_NN method_NN (_( 89.8_CD and_CC 88.7_CD %_NN ,_, respectively_RB )_) using_VBG culture_NN as_IN the_DT "_`` gold_JJ standard_NN ._SENT "_`` The_DT modified_JJ CB-18_NP protocol_NN improved_VBD the_DT sensitivity_NN of_IN CB-18_NP to_TO 71.4_CD %_NN (_( 15_CD of_IN 21_CD )_) over_IN that_DT of_IN the_DT routine_JJ protocol_NN ,_, which_WDT was_VBD 61.9_CD %_NN (_( 13_CD of_IN 21_CD )_) ;_: however_RB ,_, this_DT difference_NN was_VBD not_RB significant_JJ (_( P_NN =_SYM 0.16_CD )_) ._SENT The_DT specificities_NNS of_IN both_DT diagnostic_JJ techniques_NNS (_( CB-18_NP and_CC NALC-NaOH_NP )_) were_VBD both_DT 96.8_CD %_NN (_( 183_CD of_IN 189_CD )_) in_IN the_DT initial_JJ protocol_NN and_CC were_VBD 97.0_CD %_NN (_( 96_CD of_IN 99_CD )_) and_CC 99.0_CD %_NN (_( 98_CD of_IN 99_CD )_) ,_, respectively_RB ,_, in_IN the_DT modified_JJ protocol_NN ._SENT Even_RB with_IN the_DT modification_NN of_IN the_DT CB-18_NP processing_NN method_NN ,_, the_DT positive_JJ predictive_JJ value_NN for_IN CB-18_NP remained_VBD close_JJ to_TO that_DT of_IN routine_JJ ZN_NP due_JJ to_TO the_DT high_JJ specificity_NN of_IN both_DT methods_NNS ._SENT The_DT modified_JJ CB-18_NP protocol_NN showed_VBD an_DT improvement_NN in_IN smear_NN staining_VBG compared_VBN to_TO the_DT initial_JJ protocol_NN ,_, but_CC the_DT number_NN of_IN positive_JJ cultures_NNS was_VBD small_JJ (_( n_NN =_SYM 21_CD )_) ._SENT The_DT most_RBS notable_JJ difference_NN between_IN the_DT two_CD versions_NNS of_IN CB-18_NP processing_NN was_VBD in_IN the_DT readability_NN of_IN the_DT slides_NNS ._SENT In_IN the_DT first_JJ phase_NN ,_, 14_CD %_NN of_IN smears_NNS were_VBD not_RB readable_JJ versus_IN 1_CD %_NN (_( P_NN =_SYM 0.00_CD )_) using_VBG the_DT modified_JJ protocol_NN ._SENT Comparison_NN of_IN AFB_NP staining_VBG techniques_NNS ._SENT |_SYM A_DT comparison_NN of_IN two_CD staining_VBG techniques_NNS used_VBN in_IN AFB_NP smear_NN analysis_NN was_VBD performed_VBN on_IN 85_CD of_IN the_DT samples_NNS processed_VBD using_VBG CB-18_NP ._SENT Kinyoun_NP staining_VBG was_VBD compared_VBN to_TO ZN_NP staining_VBG to_TO determine_VB if_IN there_EX was_VBD any_DT difference_NN that_WDT would_MD affect_VB the_DT performance_NN of_IN CB-18_NP in_IN diagnostic_JJ use_NN ._SENT There_EX was_VBD fair_JJ agreement_NN between_IN the_DT two_CD techniques_NNS (_( overall_JJ agreement_NN =_SYM 72.9_CD %_NN ;_: kappa_NN test_NN =_SYM 0.715_CD )_) ._SENT However_RB ,_, 22_CD %_NN of_IN Kinyoun_NP slides_NNS and_CC 1_CD %_NN of_IN ZN_NP slides_NNS were_VBD unreadable_JJ due_RB to_TO technical_JJ problems_NNS ._SENT FIG._NN 1_CD ._SENT |_SYM Types_NNS and_CC distribution_NN of_IN respiratory_JJ specimens_NNS from_IN 356_CD patients_NNS (_( 236_CD for_IN the_DT initial_JJ phase_NN and_CC 120_CD for_IN the_DT second_JJ phase_NN of_IN the_DT study_NN )_) at_IN HUCFF_NP ._SENT Types_NNS and_CC distribution_NN of_IN respiratory_JJ specimens_NNS from_IN 356_CD patients_NNS (_( 236_CD for_IN the_DT initial_JJ phase_NN and_CC 120_CD for_IN the_DT second_JJ phase_NN of_IN the_DT study_NN )_) at_IN HUCFF_NP ._SENT All_DT samples_NNS were_VBD processed_VBN using_VBG both_CC the_DT standard_JJ method_NN and_CC the_DT CB-18_NP method_NN for_IN bacillary_JJ recovery_NN ._SENT TABLE_NN 1_CD |_SYM Evaluation_NN of_IN diagnostic_JJ methods_NNS TABLE_NP 2_CD |_SYM Evaluation_NN of_IN AFB_NP techniques_NNS The_DT CB-18_NP technique_NN is_VBZ based_VBN on_IN the_DT use_NN of_IN the_DT zwitterionic_JJ detergent_NN C18-carboxypropylbetaine_NP ._SENT Previous_JJ reports_NNS of_IN increases_NNS in_IN both_DT smear_NN and_CC culture_NN sensitivity_NN were_VBD believed_VBN to_TO result_VB from_IN a_DT reduced_VBN impact_NN on_IN viability_NN ,_, alteration_NN of_IN the_DT buoyant_JJ density_NN of_IN the_DT mycobacteria_NNS to_TO enhance_VB collection_NN efficiency_NN during_IN centrifugation_NN ,_, and_CC dispersion_NN of_IN those_DT mycobacteria_NNS that_DT cord_NN ._SENT In_IN a_DT previous_JJ study_NN the_DT CB-18_NP processing_NN method_NN used_VBD specimens_NNS derived_VBN from_IN clinical_JJ laboratories_NNS in_IN the_DT United_NP States_NPS ._SENT Those_DT authors_NNS reported_VBD an_DT increase_NN in_IN smear_NN sensitivity_NN for_IN M._NP tuberculosis_NN from_IN 69.0_CD %_NN with_IN NALC-NaOH_NP to_TO 93.1_CD %_NN with_IN CB-18_NP (_( P_NN <_SYM 0.01_CD )_) ._SENT We_PP evaluated_VBD this_DT technique_NN under_IN field_NN conditions_NNS in_IN a_DT high-prevalence_NN ,_, resource-challenged_JJ setting_NN ._SENT The_DT initial_JJ CB-18_NP protocol_NN was_VBD slightly_RB less_RBR sensitive_JJ than_IN routine_JJ smears_NNS ,_, 59.6_CD %_NN (_( 28_CD of_IN 47_CD )_) versus_CC 66.0_CD %_NN (_( 31_CD of_IN 47_CD )_) ._SENT The_DT modified_JJ CB-18_NP protocol_NN improved_VBD the_DT sensitivity_NN of_IN CB-18_NP to_TO 71_CD %_NN (_( 15_CD of_IN 21_CD )_) over_IN that_DT of_IN the_DT routine_JJ protocol_NN ,_, which_WDT was_VBD 62_CD %_NN (_( 13_CD of_IN 21_CD )_) ._SENT There_EX were_VBD no_DT significant_JJ differences_NNS in_IN the_DT sensitivity_NN or_CC specificity_NN of_IN the_DT two_CD methods_NNS for_IN either_DT version_NN of_IN CB-18_NP processing_NN ._SENT The_DT power_NN of_IN this_DT study_NN to_TO detect_VB differences_NNS in_IN the_DT two_CD techniques_NNS was_VBD limited_VBN by_IN the_DT number_NN of_IN positive_JJ cultures_NNS (_( n_NN =_SYM 68_CD )_) ,_, especially_RB in_IN the_DT second_JJ phase_NN ,_, where_WRB there_EX were_VBD only_RB 21_CD positive_JJ specimens_NNS ._SENT The_DT sensitivity_NN of_IN smear_NN improved_VBN when_WRB the_DT modified_JJ CB-18_NP protocol_NN was_VBD used_VBN ,_, but_CC the_DT increased_VBN length_NN of_IN time_NN required_VBN (_( 90-min_NN incubation_NN for_IN CB-18_NP )_) limits_VBZ its_PP$ routine_JJ utility_NN in_IN this_DT setting_NN ._SENT These_DT results_NNS are_VBP consistent_JJ with_IN the_DT findings_NNS of_IN another_DT recent_JJ evaluation_NN of_IN CB-18_NP ._SENT Comparison_NN of_IN a_DT sodium_NN dodecyl_NN sulfate-sodium_NN hydroxide_NN processing_NN method_NN with_IN a_DT CB-18_NP processing_NN protocol_NN that_WDT included_VBD no_DT incubation_NN step_NN failed_VBD to_TO show_VB improvements_NNS in_IN smear_NN sensitivity_NN ._SENT When_WRB a_DT 90-min_NN incubation_NN step_NN was_VBD included_VBN in_IN the_DT procedure_NN ,_, there_EX was_VBD a_DT small_JJ improvement_NN in_IN the_DT CB-18-based_JJ smear_NN analyses_NNS ._SENT While_IN CB-18_NP failed_VBD to_TO show_VB previously_RB described_VBN improvements_NNS in_IN the_DT diagnostic_JJ evaluation_NN of_IN TB_NN patients_NNS under_IN field_NN conditions_NNS ,_, a_DT potential_JJ limitation_NN of_IN this_DT study_NN is_VBZ that_IN M._NP tuberculosis_NN culture_NN (_( Lowerstein-Jensen_NP medium_NN )_) was_VBD used_VBN as_IN the_DT reference_NN standard_NN for_IN determining_VBG diagnostic_JJ effectiveness_NN ,_, and_CC culture_NN may_MD be_VB imperfect_JJ in_IN identifying_VBG all_DT active_JJ TB_NN cases_NNS ._SENT However_RB ,_, due_JJ to_TO the_DT high_JJ specificity_NN of_IN both_DT techniques_NNS among_IN our_PP$ samples_NNS ,_, it_PP appears_VBZ that_IN using_VBG culture_NN as_IN the_DT gold_NN standard_NN did_VBD not_RB compromise_VB our_PP$ field_NN evaluation_NN of_IN CB-_NP 18_CD ._SENT The_DT key_JJ difference_NN between_IN this_DT study_NN and_CC those_DT that_WDT have_VBP previously_RB shown_VBN a_DT higher_JJR smear_NN sensitivity_NN with_IN CB-18_NP processing_NN is_VBZ the_DT use_NN of_IN fluorochrome_NN staining_VBG methods_NNS in_IN the_DT earlier_JJR studies_NNS ._SENT Auramine-rhodamine_NN stain_NN is_VBZ a_DT more_RBR sensitive_JJ technique_NN ,_, which_WDT could_MD account_VB for_IN the_DT discrepancy_NN between_IN the_DT data_NNS presented_VBD here_RB and_CC those_DT of_IN Thornton_NP et_FW al._FW (_( -_: )_) ._SENT We_PP compared_VBD two_CD fuchsin_NN stain_NN procedures_NNS and_CC found_VBD that_DT ZN_NP staining_VBG identified_VBN twice_RB as_IN many_JJ positive_JJ smears_NNS as_IN Kinyoun_NP staining_VBG ._SENT ZN_NNS staining_VBG proved_VBN to_TO be_VB more_RBR efficient_JJ than_IN Kinyoun_NP staining_VBG for_IN analyzing_VBG CB-18-_NP processed_VBN specimens_NNS because_IN many_JJ Kinyoun-stained_NP slides_NNS were_VBD unreadable_JJ ._SENT Although_IN our_PP$ study_NN was_VBD not_RB able_JJ to_TO demonstrate_VB an_DT improvement_NN in_IN smear_NN light_JJ microscopy_NN using_VBG CB-18_NP compared_VBN to_TO digestion-decontamination_NN with_IN NALC-NaOH_NP followed_VBD by_IN centrifugation_NN ,_, CB-18_NP may_MD be_VB more_RBR useful_JJ when_WRB used_VBN in_IN conjunction_NN with_IN nucleic_JJ acid_JJ amplification_NN ,_, fluorescence_NN staining_VBG ,_, or_CC other_JJ types_NNS of_IN specimens_NNS ._SENT Published_JJ reports_NNS have_VBP shown_VBN an_DT improvement_NN in_IN the_DT recovery_NN of_IN mycobacteria_NNS other_JJ than_IN tuberculosis_NN among_IN human_JJ respiratory_JJ specimens_NNS and_CC also_RB among_IN animal_JJ products_NNS such_JJ as_IN milk_NN ._SENT CB-18_NP has_VBZ also_RB been_VBN used_VBN for_IN preparing_VBG samples_NNS for_IN amplification_NN and_CC has_VBZ been_VBN associated_VBN with_IN an_DT improvement_NN in_IN PCR_NP results_NNS compared_VBN to_TO other_JJ standard_JJ techniques_NNS ._SENT In_IN conclusion_NN ,_, in_IN our_PP$ setting_NN neither_CC the_DT original_JJ nor_CC the_DT modified_JJ CB-18_NP protocol_NN showed_VBD a_DT significant_JJ increase_NN in_IN diagnostic_JJ yield_NN of_IN light_JJ microscopy_NN smear_NN compared_VBN to_TO NALC-NaOH_NP decontamination_NN and_CC concentration_NN by_IN centrifugation_NN ._SENT A_DT larger_JJR sample_NN size_NN may_MD have_VB detected_VBN a_DT difference_NN ,_, however_RB ._SENT CB-18_JJ sample_NN processing_NN may_MD be_VB more_RBR useful_JJ when_WRB used_VBN in_IN conjunction_NN with_IN more_JJR sensitive_JJ techniques_NNS for_IN M._NP tuberculosis_NN detection_NN such_JJ as_IN fluorescence_NN microscopy_NN and_CC PCR_NP amplification_NN ._SENT Further_JJR field_NN evaluation_NN to_TO address_VB these_DT issues_NNS is_VBZ warranted_VBN ._SENT 